selected publications
- PET-guided Assessment of Amyloid Clearance and Outcomes in a Real-World Cohort of Patients with Alzheimer Disease undergoing Anti-Amyloid Therapy. AJNR. American journal of neuroradiology. 2026 Academic Article GET IT
- Dynamic Brain [F18]-Fluoroestradiol (FES) PET Protocol Optimization for Improved Detection of Breast Cancer Brain Metastases. AJNR. American journal of neuroradiology. 2026 Academic Article GET IT
-
Unraveling the Role of PET in Cervical Cancer: Review of Current Applications and Future Horizons.
Journal of imaging.
2025
Information Resource
GET IT
Times cited: 5 -
[18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases.
European journal of radiology.
2024
Academic Article
GET IT
Times cited: 4 -
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial.
The Lancet. Oncology.
2024
Academic Article
GET IT
Times cited: 41 - First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate. medRxiv : the preprint server for health sciences. 2024 Article GET IT